相关实验视频

Updated: May 6, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

临床实践中系统性红斑狼治疗策略的发展:叙述性审查

Alan D Kaye¹, Joseph P Tassin², William C Upshaw³

¹Anesthesiology, Louisiana State University Health Sciences Center, Shreveport, USA.

|January 6, 2025

概括

系统性红斑狼 (SLE) 的治疗方法正在发展. 新的生物药物如贝利马布和阿尼弗罗马布为SLE患者提供了更好的疗效和安全性,并且正在开发更多的新疗法.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
自免疫性疾病自免疫性疾病

背景情况:

系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,引起广泛的炎症和各种临床表现.
目前用于SLE的治疗方法,包括氧化,葡萄糖皮质类药物和甲铁,可能会产生显著的副作用,并且可能不会在所有患者中有效控制症状.
生物制剂的开发旨在为SLE提供更有针对性和更有效的治疗方法.

研究的目的:

审查目前和新兴的系统性红斑狼 (SLE) 治疗方法.
突出生物药物的有效性和安全性,以控制SLE.
讨论SLE目前正在研究的新型治疗策略.

主要方法:

审查关于SLE治疗的现有文献.
对贝利穆马布和阿尼弗罗卢马布等生物药物的临床试验数据的分析.
探索正在进行的关于新SLE疗法的研究,包括cenerimod和litifilimab.

主要成果:

生物药物贝利马布和阿尼弗罗马布在减少SLE症状和疾病活性方面已证明有效.
这些生物制剂通常表现出轻微的副作用,提高了它们对SLE患者的安全性.
新兴的治疗方法有希望,但需要进一步研究它们的安全性和有效性.

结论:

生物疗法在治疗SLE方面取得了重大进展,与一些传统治疗方法相比,它们提供了更好的症状控制和安全性.
目前正在进行的对新型药物的研究,如cenerimod和litifilimab,对未来的SLE治疗有潜力.
持续的研究对于充分确定新的SLE治疗方法的长期安全性和有效性至关重要.

关键词:

自身免疫性疾病是一种自身免疫性疾病.一个单克隆抗体.新的治疗方法.这是一个很棒的节目, sle sle sle sle sle sle sle sle sle sle.系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.

更多相关视频

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

相关概念视频

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...